RETN-related copper toxicosis modifier · Resistin gene copper accumulation modifier · Copper toxicosis modifier RETN · RETN copper toxicosis risk factor · Resistin-associated copper toxicosis · Copper Toxicosis (Modifier, RETN-related)
This genetic variant in the RETN gene acts as a modifier for copper toxicosis, a metabolic condition affecting the liver. It does not cause the disease on its own, but it influences how severely copper accumulates in the liver tissue. This accumulation can lead to progressive liver damage and inflammation.
Owners may notice signs of liver dysfunction, such as vomiting, lethargy, weight loss, or a yellowish tint to the skin and gums (jaundice). These symptoms typically become apparent in middle-aged dogs when the underlying copper storage disease is present.
While the modifier itself is not treated, the underlying copper accumulation requires lifelong management with a low-copper diet and copper-chelating medications. Regular veterinary monitoring is necessary, with lifetime treatment costs typically ranging from 1,500 to 6,000 EUR.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.
More conditions affecting the General / metabolic.